AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

4D Molecular Therapeutics, Inc.

$11.90 +$4.58 (+62.57%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$12.78
Day Range
$11.73$12.80
Year Range
$6.96$16.93
Market Cap
657.41M
AVG Volume
971.77K
Trailing/Forward PE
-4.38/-
PEG ratio
-0.16
Dividend Yield
-
Next Earnings Date
2026-11-10
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
025M50M75M100M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
FDMT Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q292.01M
26 Q188.24M
25 Q485.21M
25 Q3120K
25 Q233K
25 Q123K
24 Q437K
24 Q317K
24 Q220.22M
24 Q120.45M
Net Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
FDMT Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-179.18M
26 Q1-160.9M
25 Q4-140.11M
25 Q3-209.18M
25 Q2-196.14M
25 Q1-176.44M
24 Q4-160.87M
24 Q3-143.48M
24 Q2-109.89M
24 Q1-104.56M
Operating Income (USD) · TTM
-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
FDMT Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-197.12M
26 Q1-179.55M
25 Q4-159.55M
25 Q3-230.38M
25 Q2-220.33M
25 Q1-203.33M
24 Q4-187.84M
24 Q3-168.38M
24 Q2-131.22M
24 Q1-120.9M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: FDMT

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 10 Nov 2026.

4D Molecular Therapeutics, Inc.
FDMT
Stockpicker

Video analysis: FDMT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: FDMT

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.